Lilly's earnings fell 5% as the drug maker took charges tied to health reform and increased spending on research, development and marketing.
WSJ.com: What's News US, Wall Street Journal: Home US
Mon, 04/19/2010 - 4:49am
Lilly's earnings fell 5% as the drug maker took charges tied to health reform and increased spending on research, development and marketing.